Johnson & Johnson

01/15/2025 | Press release | Distributed by Public on 01/15/2025 07:01

New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug releasing system for patients with BCG-unresponsive high-risk non-muscle-invasive[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.